Dual potency anti-HER2/neu and anti-EGFR anthracycline immunoconjugates in chemotherapeutic-resistant mammary carcinoma combined with cyclosporin A and verapamil P-glycoprotein inhibition.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples